Benzoyl Peroxide; Clindamycin Phosphate Patent Expiration
Benzoyl Peroxide; Clindamycin Phosphate was first introduced by Bausch Health Americas Inc
Benzoyl Peroxide; Clindamycin Phosphate Patents
Given below is the list of patents protecting Benzoyl Peroxide; Clindamycin Phosphate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Acanya | US10220049 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
| Acanya | US10624918 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
| Acanya | US5733886 | Compositions of clindamycin and benzoyl peroxide for acne treatment |
Mar 31, 2015
(Expired) | Bausch |
| Acanya | US8288434 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Aug 05, 2029 | Bausch |
| Acanya | US8663699 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
| Acanya | US8895070 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
| Acanya | US9078870 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
| Duac | US5466446 | Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof |
Feb 16, 2014
(Expired) | Stiefel |
| Onexton | US10137142 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
| Onexton | US10220049 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
| Onexton | US5733886 | Compositions of clindamycin and benzoyl peroxide for acne treatment |
Mar 31, 2015
(Expired) | Bausch |
| Onexton | US8288434 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Aug 05, 2029 | Bausch |
| Onexton | US9504704 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
| Onexton | US9561208 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Benzoyl Peroxide; Clindamycin Phosphate Generics
Several generic applications have been filed for Benzoyl Peroxide; Clindamycin Phosphate. The first generic version for Benzoyl Peroxide; Clindamycin Phosphate was by Mylan Pharmaceuticals Inc and was approved on Aug 11, 2009. And the latest generic version is by Encube Ethicals Private Ltd and was approved on Apr 28, 2021.
Given below is the list of companies who have filed for Benzoyl Peroxide; Clindamycin Phosphate generic.
1. TARO
Taro Pharmaceuticals Inc has filed for 4 different strengths of generic version for Benzoyl Peroxide; Clindamycin Phosphate. All of these versions come by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5%; 1.2% | gel | Prescription | TOPICAL | AB | Dec 15, 2017 |
| 5%; EQ 1% BASE | gel | Prescription | TOPICAL | AB | May 25, 2018 |
| 3.75%; EQ 1.2% BASE | gel | Prescription | TOPICAL | AB | Jun 5, 2018 |
| 2.5%; EQ 1.2% BASE | gel | Prescription | TOPICAL | AB | Aug 19, 2019 |
2. ENCUBE
Encube Ethicals Private Ltd has filed for 3 different strengths of generic version for Benzoyl Peroxide; Clindamycin Phosphate. All of these versions come by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Encube.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5%; EQ 1% BASE | gel | Discontinued | TOPICAL | N/A | Jun 27, 2017 |
| 2.5%; EQ 1.2% BASE | gel | Discontinued | TOPICAL | N/A | Aug 19, 2019 |
| 5%; 1.2% | gel | Prescription | TOPICAL | AB | Apr 28, 2021 |
3. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 1 generic for Benzoyl Peroxide; Clindamycin Phosphate. This 5%;eq 1% base version comes by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5%; EQ 1% BASE | gel | Prescription | TOPICAL | AB | Aug 11, 2009 |
4. ACTAVIS LABS UT INC
Actavis Laboratories Ut Inc has filed for 1 generic for Benzoyl Peroxide; Clindamycin Phosphate. This 2.5%;eq 1.2% base version comes by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Actavis Labs Ut Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5%; EQ 1.2% BASE | gel | Prescription | TOPICAL | AB | Jun 19, 2015 |
5. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Benzoyl Peroxide; Clindamycin Phosphate. This 5%;1.2% version comes by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5%; 1.2% | gel | Discontinued | TOPICAL | N/A | Aug 25, 2016 |
6. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Benzoyl Peroxide; Clindamycin Phosphate. This 5%;1.2% version comes by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5%; 1.2% | gel | Prescription | TOPICAL | AB | Dec 28, 2018 |
7. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 1 generic for Benzoyl Peroxide; Clindamycin Phosphate. This 5%;eq 1% base version comes by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5%; EQ 1% BASE
(reference standard) | gel | Prescription | TOPICAL | AB | Mar 14, 2019 |
8. PADAGIS ISRAEL
Padagis Israel Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Benzoyl Peroxide; Clindamycin Phosphate. All of these versions come by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Padagis Israel.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5%; 1.2%
(reference standard) | gel | Prescription | TOPICAL | AB | Jun 26, 2012 |
| 5%; EQ 1% BASE | gel | Prescription | TOPICAL | AB | Sep 21, 2015 |
| 2.5%; EQ 1.2% BASE | gel | Prescription | TOPICAL | AB | Sep 9, 2019 |